Pharma / Biotech

Xerava Shown Effective in High-Risk Patients With cIAIs

Xerava was effective in treating patients with complicated intra-abdominal infectionswho had characteristics that are associated with poor outcomes, according to a poster presented at the 2019 annual MAD-ID (Making a Difference in Infectious Diseases) meeting.

Source link

Related posts

OXYGEN gas [SCM Trueair Technologies Inc.]


Glucuronidation and its effect on the bioactivity of amentoflavone, a biflavonoid from Ginkgo biloba leaves.


DOACs Can Deliver for VTE in Patients With Cancer


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy